| Literature DB >> 31591207 |
Chenxia He1, Jeanne M Danes1, Peter C Hart2, Yueming Zhu3, Yunping Huang1, Andre Luelsdorf de Abreu2, Joseph O'Brien3, Angela J Mathison4, Binwu Tang5, Jonna M Frasor6, Lalage M Wakefield5, Douglas Ganini7, Erich Stauder8, Jacek Zielonka8, Benjamin N Gantner1, Raul A Urrutia4, David Gius3, Marcelo G Bonini9.
Abstract
Mitochondrial superoxide dismutase (SOD2) suppresses tumor initiation but promotes invasion and dissemination of tumor cells at later stages of the disease. The mechanism of this functional switch remains poorly defined. Our results indicate that as SOD2 expression increases acetylation of lysine 68 ensues. Acetylated SOD2 promotes hypoxic signaling via increased mitochondrial reactive oxygen species (mtROS). mtROS, in turn, stabilize hypoxia-induced factor 2α (HIF2α), a transcription factor upstream of "stemness" genes such as Oct4, Sox2, and Nanog. In this sense, our findings indicate that SOD2K68Ac and mtROS are linked to stemness reprogramming in breast cancer cells via HIF2α signaling. Based on these findings we propose that, as tumors evolve, the accumulation of SOD2K68Ac turns on a mitochondrial pathway to stemness that depends on HIF2α and may be relevant for the progression of breast cancer toward poor outcomes.Entities:
Keywords: MnSOD; SOD2; acetylation; breast cancer; stem cells
Mesh:
Substances:
Year: 2019 PMID: 31591207 PMCID: PMC6876149 DOI: 10.1073/pnas.1902308116
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205